Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.14 - $0.39 $1,168 - $3,255
-8,347 Reduced 44.64%
10,351 $2,000
Q3 2023

Nov 09, 2023

BUY
$0.34 - $1.23 $5,336 - $19,306
15,696 Added 522.85%
18,698 $6,000
Q2 2023

Aug 09, 2023

SELL
$0.69 - $1.46 $8,134 - $17,211
-11,789 Reduced 79.7%
3,002 $3,000
Q1 2023

May 12, 2023

SELL
$0.64 - $1.45 $3,498 - $7,925
-5,466 Reduced 26.98%
14,791 $10,000
Q4 2022

Feb 09, 2023

BUY
$1.1 - $1.74 $22,282 - $35,247
20,257 New
20,257 $22,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Better Therapeutics, Inc.


  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.